Pfizer Earnings beat, Revenue misses In Q4

  • Investing.com
  • Stock Market News
Pfizer Earnings beat, Revenue misses In Q4

Investing.com - Pfizer (NYSE: PFE ) reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

Pfizer announced earnings per share of $1.08 on revenue of $23.84B. Analysts polled by Investing.com anticipated EPS of $0.8742 on revenue of $24.16B.

Pfizer shares are down 9% from the beginning of the year and are trading at $53.21 , down-from-52-week-high.They are under-performing the S&P Global 100 which is down 2.19% from the start of the year.

Pfizer follows other major Healthcare sector earnings this month

Pfizer's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.

J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100